152 related articles for article (PubMed ID: 37150325)
1. The T1150A cancer mutant of the protein lysine dimethyltransferase NSD2 can introduce H3K36 trimethylation.
Khella MS; Schnee P; Weirich S; Bui T; Bröhm A; Bashtrykov P; Pleiss J; Jeltsch A
J Biol Chem; 2023 Jun; 299(6):104796. PubMed ID: 37150325
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of the regulation of the normal and oncogenic methylation of nucleosomal histone H3 Lys36 by NSD2.
Sato K; Kumar A; Hamada K; Okada C; Oguni A; Machiyama A; Sakuraba S; Nishizawa T; Nureki O; Kono H; Ogata K; Sengoku T
Nat Commun; 2021 Nov; 12(1):6605. PubMed ID: 34782608
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of nucleosomal H3K36 methylation by NSD methyltransferases.
Li W; Tian W; Yuan G; Deng P; Sengupta D; Cheng Z; Cao Y; Ren J; Qin Y; Zhou Y; Jia Y; Gozani O; Patel DJ; Wang Z
Nature; 2021 Feb; 590(7846):498-503. PubMed ID: 33361816
[TBL] [Abstract][Full Text] [Related]
4. In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L.
Morishita M; Mevius D; di Luccio E
BMC Struct Biol; 2014 Dec; 14():25. PubMed ID: 25494638
[TBL] [Abstract][Full Text] [Related]
5. The H3.3 G34W oncohistone mutation increases K36 methylation by the protein lysine methyltransferase NSD1.
Bröhm A; Schoch T; Grünberger D; Khella MS; Schuhmacher MK; Weirich S; Jeltsch A
Biochimie; 2022 Jul; 198():86-91. PubMed ID: 35341929
[TBL] [Abstract][Full Text] [Related]
6. The NSD family of protein methyltransferases in human cancer.
Vougiouklakis T; Hamamoto R; Nakamura Y; Saloura V
Epigenomics; 2015 Aug; 7(5):863-74. PubMed ID: 25942451
[TBL] [Abstract][Full Text] [Related]
7. The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors.
Topchu I; Pangeni RP; Bychkov I; Miller SA; Izumchenko E; Yu J; Golemis E; Karanicolas J; Boumber Y
Cell Mol Life Sci; 2022 May; 79(6):285. PubMed ID: 35532818
[TBL] [Abstract][Full Text] [Related]
8. Depletion of Nsd2-mediated histone H3K36 methylation impairs adipose tissue development and function.
Zhuang L; Jang Y; Park YK; Lee JE; Jain S; Froimchuk E; Broun A; Liu C; Gavrilova O; Ge K
Nat Commun; 2018 May; 9(1):1796. PubMed ID: 29728617
[TBL] [Abstract][Full Text] [Related]
9. Transition state for the NSD2-catalyzed methylation of histone H3 lysine 36.
Poulin MB; Schneck JL; Matico RE; McDevitt PJ; Huddleston MJ; Hou W; Johnson NW; Thrall SH; Meek TD; Schramm VL
Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1197-201. PubMed ID: 26787850
[TBL] [Abstract][Full Text] [Related]
10. Histone H2A ubiquitination inhibits the enzymatic activity of H3 lysine 36 methyltransferases.
Yuan G; Ma B; Yuan W; Zhang Z; Chen P; Ding X; Feng L; Shen X; Chen S; Li G; Zhu B
J Biol Chem; 2013 Oct; 288(43):30832-42. PubMed ID: 24019522
[TBL] [Abstract][Full Text] [Related]
11. The structure of NSD1 reveals an autoregulatory mechanism underlying histone H3K36 methylation.
Qiao Q; Li Y; Chen Z; Wang M; Reinberg D; Xu RM
J Biol Chem; 2011 Mar; 286(10):8361-8368. PubMed ID: 21196496
[TBL] [Abstract][Full Text] [Related]
12. The Benzene Hematotoxic and Reactive Metabolite 1,4-Benzoquinone Impairs the Activity of the Histone Methyltransferase SET Domain Containing 2 (SETD2) and Causes Aberrant Histone H3 Lysine 36 Trimethylation (H3K36me3).
Berthelet J; Michail C; Bui LC; Le Coadou L; Sirri V; Wang L; Dulphy N; Dupret JM; Chomienne C; Guidez F; Rodrigues-Lima F
Mol Pharmacol; 2021 Sep; 100(3):283-294. PubMed ID: 34266924
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of histone methylation catalyzed by protein lysine methyltransferase SET7/9 and origin of product specificity.
Guo HB; Guo H
Proc Natl Acad Sci U S A; 2007 May; 104(21):8797-802. PubMed ID: 17517655
[TBL] [Abstract][Full Text] [Related]
14. NSD2 as a Promising Target in Hematological Disorders.
Azagra A; Cobaleda C
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232375
[TBL] [Abstract][Full Text] [Related]
15. NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming.
Kuo AJ; Cheung P; Chen K; Zee BM; Kioi M; Lauring J; Xi Y; Park BH; Shi X; Garcia BA; Li W; Gozani O
Mol Cell; 2011 Nov; 44(4):609-20. PubMed ID: 22099308
[TBL] [Abstract][Full Text] [Related]
16. Substrate specificity analysis and novel substrates of the protein lysine methyltransferase NSD1.
Kudithipudi S; Lungu C; Rathert P; Happel N; Jeltsch A
Chem Biol; 2014 Feb; 21(2):226-37. PubMed ID: 24412544
[TBL] [Abstract][Full Text] [Related]
17. Role of somatic cancer mutations in human protein lysine methyltransferases.
Kudithipudi S; Jeltsch A
Biochim Biophys Acta; 2014 Dec; 1846(2):366-79. PubMed ID: 25123655
[TBL] [Abstract][Full Text] [Related]
18. An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia.
Swaroop A; Oyer JA; Will CM; Huang X; Yu W; Troche C; Bulic M; Durham BH; Wen QJ; Crispino JD; MacKerell AD; Bennett RL; Kelleher NL; Licht JD
Oncogene; 2019 Jan; 38(5):671-686. PubMed ID: 30171259
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation analysis of multiple imprinted DMRs in Sotos syndrome reveals IGF2-DMR0 as a DNA methylation-dependent, P0 promoter-specific enhancer.
Watanabe H; Higashimoto K; Miyake N; Morita S; Horii T; Kimura M; Suzuki T; Maeda T; Hidaka H; Aoki S; Yatsuki H; Okamoto N; Uemura T; Hatada I; Matsumoto N; Soejima H
FASEB J; 2020 Jan; 34(1):960-973. PubMed ID: 31914674
[TBL] [Abstract][Full Text] [Related]
20. Systematic perturbations of SETD2, NSD1, NSD2, NSD3 and ASH1L reveals their distinct contributions to H3K36 methylation.
Shipman GA; Padilla R; Horth C; Hu B; Bareke E; Vitorino FN; Gongora JM; Garcia BA; Lu C; Majewski J
bioRxiv; 2023 Oct; ():. PubMed ID: 37905045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]